New York A11627 mandates insurance coverage for ameloblastoma treatment, including dental implants.
New York A11627 amends the insurance law to require coverage for medically necessary dental services related to ameloblastoma treatment, including dental implants and implant-related services. This applies to policies providing major medical or similar comprehensive-type coverage, as well as group or blanket policies for dental services. The coverage must be provided to insureds who have experienced tooth loss or removal due to ameloblastoma treatment. The act takes effect immediately for policies issued, renewed, modified, altered, or amended on or after the effective date.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.